Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach

被引:12
|
作者
Chen, Yongsheng [2 ]
Teng, Lichen [2 ]
Liu, Wenhua [3 ]
Cao, Yan [2 ]
Ding, Dexin [2 ]
Wang, Wentao [2 ]
Chen, Hui [2 ]
Li, Changfu [2 ]
An, Ruihua [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Urol, 31 Youzheng St, Harbin 150001, Province Heilon, Peoples R China
[2] Harbin Med Univ, Canc Hosp, Dept Urol, Harbin 150040, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, ICU Dept, Harbin 150086, Province Heilon, Peoples R China
关键词
Clear cell renal cell carcinoma; MicroRNAs; Differentially expressed genes; Protein-protein interaction; DEPENDENT REGULATION; GENE-EXPRESSION; KIDNEY CANCER; V COLLAGEN; NORMALIZATION; RNA; METABOLISM; MICRORNAS; MIGRATION; DIAGNOSIS;
D O I
10.1186/s12935-016-0291-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We aimed to discover the potential microRNA (miRNA) targets and to explore the underlying molecular mechanisms of clear cell renal cell carcinoma (ccRCC). Methods: Microarray data of GSE16441 was downloaded from Gene Expression Omnibus database. Differentially expressed genes (DEGs) and differentially expressed miRNAs between ccRCC tumors and matched non-tumor samples were analyzed. Target genes of differentially expressed miRNAs were screened. Besides, functional enrichment analysis of DEGs was performed, followed by protein-protein interaction (PPI) network construction and sub-module analysis. Finally, the integrated miRNA-DEGs network was constructed. Results: A total of 1758 up- and 2465 down-regulated DEGs were identified. Moreover, 15 up- and 12 down-regulated differentially expressed miRNAs were screened. The up-regulated DEGs were significantly enriched in pathways such as cell adhesion molecules and focal adhesion. Besides, the down-regulated DEGs were enriched in oxidative phosphorylation, and citrate cycle (TCA cycle). Moreover, eight sub-modules of PPI network were obtained. Totally, eight down-regulated miRNAs were identified to significantly regulate the DEGs and miRNA-200c that could regulate collagen, type V, alpha 2 (COL5A2) as well as COL5A3 was found to be the most significant. Additionally, 10 up-regulated miRNAs were identified to be significantly associated with the DEGs. Thereinto, miRNA-15a that could regulate ATPase, H+ transporting, lysosomal 21 kDa, V0 subunit b (ATP6V0B) and miRNA-155 were found to be the most significant. Conclusions: miRNA-200c that could regulate COL5A2 and COL5A3, miRNA-15a that could regulate ATP6V0B and miRNA-155 may play key roles in ccRCC progression. These miRNAs may be potential targets for ccRCC treatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
    Seidel, Philipp
    Rubarth, Anne
    Zodel, Kyra
    Peighambari, Asin
    Neumann, Felix
    Federkiel, Yannick
    Huang, Hsin
    Hoefflin, Rouven
    Adlesic, Mojca
    Witt, Christian
    Hoffmann, David J.
    Metzger, Patrick
    Lindemann, Ralph K.
    Zenke, Frank T.
    Schell, Christoph
    Boerries, Melanie
    von Elverfeldt, Dominik
    Reichardt, Wilfried
    Follo, Marie
    Albers, Joachim
    Frew, Ian J.
    JCI INSIGHT, 2022, 7 (24)
  • [42] Cuproptosis: A potential therapeutic target in clear cell renal cell carcinoma
    Zhao Yuetong
    Li Jie
    Lu Xiaojie
    Wu Shuang
    Xing Yunze
    Fang Yaxuan
    Yang Bo
    中华医学杂志英文版, 2024, 137 (11)
  • [43] Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
    Jeong, Eun-jeong
    Kim, Eunjeong
    Kim, Yeon Soo
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [44] MicroRNAs in clear cell renal cell carcinoma: biological functions and applications
    Aguiari, Gianluca
    JOURNAL OF KIDNEY CANCER AND VHL, 2015, 2 (04): : 140 - 152
  • [45] Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis
    Xu, Tianbo
    Ruan, Hailong
    Song, Zhengshuai
    Cao, Qi
    Wang, Keshan
    Bao, Lin
    Liu, Di
    Tong, Junwei
    Yang, Hongmei
    Chen, Ke
    Zhang, Xiaoping
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [46] Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis
    Zhai, Wenxin
    Lu, Haijiao
    Dong, Shenghua
    Fang, Jing
    Yu, Zhuang
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2020, 52 (08) : 853 - 863
  • [47] Identification of microRNA editing sites in clear cell renal cell carcinoma
    Liu, Yulong
    Guo, Shiyong
    Xie, Wenping
    Yang, Huaide
    Li, Wanran
    Zhou, Nan
    Yang, Jun
    Zhou, Guangchen
    Mao, Chunyi
    Zheng, Yun
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Identification of microRNA editing sites in clear cell renal cell carcinoma
    Yulong Liu
    Shiyong Guo
    Wenping Xie
    Huaide Yang
    Wanran Li
    Nan Zhou
    Jun Yang
    Guangchen Zhou
    Chunyi Mao
    Yun Zheng
    Scientific Reports, 13
  • [49] Identification of novel epigenetic markers for clear cell renal cell carcinoma
    Dalgin, Gul S.
    Drever, Michele
    Williams, Tara
    King, Thomas
    DeLisi, Charles
    Liou, Louis S.
    JOURNAL OF UROLOGY, 2008, 180 (03): : 1126 - 1130
  • [50] Identification of potential serum markers in clear cell renal cell carcinoma
    Crispen, Paul L.
    Magera, James S.
    Boorjian, Stephen A.
    Thompson, R. Houston
    Lohse, Christine M.
    Blute, Michael L.
    Leibovich, Bradley C.
    Kwon, Eugene D.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 166 - 167